Lidocaine Hydrochloride Jelly
Product Images NDC 51662-1552

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 51662-1552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (51662 1552 2 Pouch Labeling)

Pouch Labeling (51662 1552 2 Pouch Labeling)
This is a description of a topical anesthetic medication called Lidocaine Hydrochloride Jelly USP, 2%, with a total of 200mg and concentration of 20mg/mL in a 10mL URO-JET tube. The product is for single-use only, has no preservative added, and should be stored at a controlled room temperature between 15° to 30°C (59° to 86°F). The package must not be opened until ready to use, and instructions suggest using an aseptic technique when assembling the syringe. The medication's usual dosage should be viewed on the insert, and the product is for topical use only. The manufacturer's information, which includes the NDC and name, is available on the package. It is only available by prescription. However, some sections, such as the ones containing the numbers and symbols, seem unreadable due to errors.*
FDA Label Image

Case Labeling (51662 1552 3 Case Labeling)

Case Labeling (51662 1552 3 Case Labeling)
Lidocaine Hydrochloride Jelly is a topical local anesthetic medication. It is available in the form of URO-JET® syringe containing 2% Lidocaine Hydrochloride (200mg) in a 10mL solution. The package comes in a box containing 25 syringes. The dosage should be as per the insert. The syringe needs to be assembled using aseptic technique before use. The package is not to be opened until ready to use. The product needs to be stored at a controlled temperature of 15° to 30°C (59° to 86°F). The medicine does not contain any preservatives. The original manufacturing NDC of the product is76329-3013-5.*
FDA Label Image

Serialized Label (51662 1552 3 Serialized Labeling)

FDA Label Image

Description (Description)

FDA Label Image

Hs1 (How Supplied 1)

FDA Label Image

Hs2 (How Supplied 2)

FDA Label Image

Hs3 (How Supplied 3)

FDA Label Image

Urojet (Urojet Labeling)

Urojet (Urojet Labeling)
This is a description of a package of Lidocaine Hydrochloride Jelly USP, 2% in a 10mL syringe assembly for topical use as a local anesthetic. It contains 20mg of Lidocaine Hydrochloride per ml and sodium carboxymethylcellulose. The pH is adjusted with sodium hydroxide to meet USP limits of 6 to 7. The package is sterile, and the instructions advise not to open until ready to use, and to use aseptic technique when assembling the syringe. The package is made by International Medication Systems, Limited, located in So. El Monte, CA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.